ARCHIVES

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

What Should NCI Do When Center Directors Leave? Kimes Asks

July 24, 1992

Core Grant Guideline Revisions, Comprehensive Center Characteristics Changes Still Coming Up

July 13, 1979

Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models

November 20, 1998

Animas As Early Warning “Sentinels” Part Of DCE Study

July 31, 1987

New Cooperative Group Funded

September 30, 1977

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

November 9, 2001